Singapore Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

---

Industry Assessment Overview

Industry Findings: The rise of national interoperability standards is reframing procurement and product design: regulators and hospital groups now demand device data models that plug into unified clinical records and remote-monitoring frameworks. HSA’s product-registration guidance update (GN-Mar-2024) and subsequent licensing guidance push vendors to provide clearer change-management documentation and interface definitions. Vendors that demonstrate plug-and-play interoperability and robust lifecycle-change controls gain priority in public and private tenders.

Industry Progression: Momentum moved decisively when national standards to boost digital-health interoperability and remote clinical monitoring were announced (national standards published in Oct-2025). That policy-level move accelerates sandbox testing and shortens procurement pilots for remote-monitoring solutions, increasing hospital willingness to adopt cloud-connected devices and favouring vendors who can validate conformance quickly.

Industry Player Insights: Among the many companies in this market, a few include Philips Healthcare, Roche Diagnostics, Siemens Healthineers, and Veredus Laboratories etc. Singapore’s vendor mix is shifting toward integrated solutions: Philips’ collaboration with Singapore General Hospital to advance imaging training and deployments (Dec-2024) and Veredus’s local IVD approvals (IVD approval for OSOM Strep A, Apr-2023) show how global and local suppliers combine to meet interoperability and regulatory expectations. These developments push buyers toward vendors that can deliver validated devices, training and local regulatory support.